⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for 5 fu

Every month we try and update this database with for 5 fu cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell CarcinomaNCT00176280
Renal Cell Carc...
Leukine
Dexamethasone
18 Years - University of Kentucky
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract.NCT00448136
Neoplasms
bevacizumab [Av...
5 FU
Streptozotocin
Xeloda
18 Years - Hoffmann-La Roche
Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal AdenocarcinomaNCT05546853
Pancreatic Duct...
NP137
Oxaliplatin
Irinotecan
Calcium levofol...
5 FU
18 Years - University Hospital, Grenoble
A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)NCT05472259
Metastatic Panc...
Nanoliposomal i...
5 FU
Leucovorin
Oxaliplatin
18 Years - Belgian Group of Digestive Oncology
Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.NCT01858649
Metastatic Colo...
Metastases rese...
Bevacizumab
5 FU
Oxaliplatin
Irinotecan
18 Years - Cliniques universitaires Saint-Luc- Université Catholique de Louvain
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal CancerNCT00069108
Colorectal Canc...
5 FU
Leucovorin
Oxaliplatin
Oxaliplatin
capecitabine [X...
18 Years - Hoffmann-La Roche
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.NCT00577109
Colorectal Canc...
bevacizumab [Av...
Irinotecan
Leucovorin
5 FU
Cetuximab
18 Years - Hoffmann-La Roche
Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract CancersNCT01926236
Biliary Tract C...
Gallbladder Can...
Cholangiocarcin...
Ampullary Cance...
Active Symptom ...
L-folinic acid
5 FU
Oxaliplatin
18 Years - The Christie NHS Foundation Trust
Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.NCT01858649
Metastatic Colo...
Metastases rese...
Bevacizumab
5 FU
Oxaliplatin
Irinotecan
18 Years - Cliniques universitaires Saint-Luc- Université Catholique de Louvain
A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)NCT05472259
Metastatic Panc...
Nanoliposomal i...
5 FU
Leucovorin
Oxaliplatin
18 Years - Belgian Group of Digestive Oncology
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract.NCT00448136
Neoplasms
bevacizumab [Av...
5 FU
Streptozotocin
Xeloda
18 Years - Hoffmann-La Roche
Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell CarcinomaNCT00176280
Renal Cell Carc...
Leukine
Dexamethasone
18 Years - University of Kentucky
Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract CancersNCT01926236
Biliary Tract C...
Gallbladder Can...
Cholangiocarcin...
Ampullary Cance...
Active Symptom ...
L-folinic acid
5 FU
Oxaliplatin
18 Years - The Christie NHS Foundation Trust
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: